BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC on December 17, 2024.
The net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Proposed Public Offering
BioSig Technologies, Inc. intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Offering Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- BioSig Technologies plans to create liquidity through the public offering of its shares.
- The offering is part of BioSig's strategy to fund its investment policy and enhance its working capital.
The proposed public offering signifies BioSig Technologies' strategic move to enhance its financial resources and pursue its investment policy. It reflects the company's confidence in its growth prospects and commitment to strengthening its financial position.